$UNH
UnitedHealth Group Inc.
Largest U.S. health insurer with Optum health services division.
UNH key facts as of November 14, 2026
- Latest AI research report
- UNH Stock: Optum Growth, Valuation and Risks (as of November 14, 2026)
- StockAlpha report sentiment
- Neutral (as of November 14, 2026)
- Analyst consensus
- Strong Buy (7 Strong Buy, 15 Buy, 5 Hold, 0 Sell, 0 Strong Sell) (as of November 1, 2026)
- Analyst price target
- $477.50 mean (range $380.00 to $531.00) (as of November 20, 2026)
- Sector
- Healthcare
Analysis from Nov 13, 2026
UNH Stock: Optum Growth, Valuation and Risks
UnitedHealth closed at $407.46 on Friday, November 13, after its latest quarterly earnings beat estimates and Optum Rx expanded operating earnings despite lower prescription volumes. The outlook is balanced: earnings growth and analyst targets offer support, while revenue softness, industry pressures and execution risks remain important.
Previous Reports
UNH FAQ
What is StockAlpha's latest view on UNH?
StockAlpha's latest AI research report on UnitedHealth Group Inc. (UNH), "UNH Stock: Optum Growth, Valuation and Risks", was published on November 14, 2026 and rates the overall sentiment as neutral. UnitedHealth closed at $407.46 on Friday, November 13, after its latest quarterly earnings beat estimates and Optum Rx expanded operating earnings despite lower prescription volumes. The outlook is balanced: earnings growth and analyst targets offer support, while revenue softness, industry pressures and execution risks remain important.
When was the UNH research last updated?
The most recent UNH report was published on November 14, 2026.
What do analysts expect for UNH?
As of November 1, 2026, the analyst consensus on UNH is Strong Buy (7 Strong Buy, 15 Buy, 5 Hold, 0 Sell, 0 Strong Sell). As of November 20, 2026, the analyst price target is $477.50 mean (range $380.00 to $531.00).
Is this UNH research investment advice?
No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.
Keep exploring
- draft UnitedHealth Group into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on UnitedHealth Group's peers: Today's sector-level news and moves around the stock